Lays groundwork for multiple submissions across cancer types, starting with CDx label in bladder cancerNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced the submission of the first
The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.